Todd Baszucki Amends Know Labs Stake

TL;DR

Baszucki updated his Know Labs filing, watch for changes.

AI Summary

Todd Baszucki, filing Amendment No. 1 to Schedule 13D on June 3, 2024, has reported a change in beneficial ownership for Know Labs, Inc. The filing indicates a shift in his stake, though specific new ownership percentages or dollar amounts are not detailed in this excerpt. The event triggering this amendment occurred on October 16, 2023.

Why It Matters

This filing indicates a change in a significant shareholder's stake in Know Labs, Inc., which could signal shifts in control or strategy for the company.

Risk Assessment

Risk Level: medium — Schedule 13D filings often precede significant corporate actions or shifts in control, introducing potential volatility.

Key Players & Entities

• Todd Baszucki (person) — Filing person and beneficial owner
• Know Labs, Inc. (company) — Subject company
• 499238103 (other) — CUSIP Number for Know Labs, Inc. Common Stock

FAQ

Key Financial Figures

• $0.001 — me of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securiti
• $0.6799 — of common stock at a purchase price of $0.6799 per shares through open market purchase
• $0.6299 — of common stock at a purchase price of $0.6299 per share through open market purchases
• $0.5675 — of common stock at a purchase price of $0.5675 per share through open market purchases
• $0.25 — ed 14,000,000 shares of common stock at $0.25 per share pursuant to Issuer’s Re
• $0.4538 — res of common stock at a sales price of $0.4538 per share through open market sales. S
• $0.3607 — res of common stock at a sales price of $0.3607 per share through open market sales. S
• $0.2360 — res of common stock at a sales price of $0.2360 per share through open market sales. S
• $0.2406 — res of common stock at a sales price of $0.2406 per share through open market sales. (

Filing Documents

• ea0207268-13da1baszucki_know.htm (SC 13D/A) — 36KB
• 0001213900-24-048944.txt ( ) — 37KB

Security and Issuer

Item 1. Security and Issuer Todd Baszucki (the “Reporting Person”) previously filed a Schedule 13G on April 12, 2022, as amended February 14, 2023 (the “Schedule 13G”). This amendment is a result of an increase of the outstanding common stock of the Issuer (defined below) and not due to any change in the ownership position of the Reporting Person. This Schedule 13D/A (this “Schedule 13D”) relates to the common stock (the “Common Stock”) of Know Labs, Inc. fka Visualant, Incorporated , a Nevada corporation (the “Issuer” or “Registrant”), and amends the Schedule 13G. The address of the principal executive offices of the Issuer is 500 Union St, Suite 810, Seattle, WA 98101, its telephone number is (206)903-1351

Identity and Background

Item 2. Identity and Background (a) This Schedule 13D/A is being filed by Todd Baszucki (the “Reporting Person”). (b) The principal business address for the Reporting Person is 395 Del Monte Center, #306 Monterey, CA 93940 (c) The principal occupation of the Reporting Person is a self employed, private investor, the business address of which is 395 Del Monte Center, #306 Monterey, CA 93940. (d) The Reporting Person has not been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors) during the last five years. (e) During the last five years, the Reporting Person has not been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws. (f) The Reporting Person is a citizen of the United States.

Source and Amount of Funds or Other

Item 3. Source and Amount of Funds or Other Consideration The Reporting Person used cash to make the purchases of Common Stock.

Purpose of Transaction

Item 4. Purpose of Transaction The Common Stock was acquired for, and are being held for, investment purposes. Depending on the factors discussed herein, the Reporting Person may, from time to time, acquire additional shares of Common Stock and/or retain and/or sell all or a portion of the shares of Common Stock held by the Reporting Person in the open market or in privately negotiated transactions, and/or may distribute the Common Stock held by the Reporting Person to other entities. Any actions the Reporting Person might undertake will be dependent upon the Reporting Person’s review of numerous factors, including, among other things, the price levels of the Common Stock, general market and economic conditions, ongoing evaluation of the Issuer’s business, financial condition, operations and prospects, the relative attractiveness of alternative business and investment opportunities, investor’s need for liquidity, and other future developments. The Reporting Person has no present intention to sell any shares of Common Stock, although any Reporting Person could determine from time to time, based upon the same factors listed above for purchases, to sell some or all of the shares of Common Stock held by such Reporting Person. The Reporting Person does not have any plans or intentions that would result in any of the actions or transactions described in clauses (a)through (j) of Item 4 of Schedule 13D, except as previously disclosed in this Schedule 13D, or as set forth above.

Interest in Securities of the Issuer

Item 5. Interest in Securities of the Issuer (a) As of October 16, 2023, Mr. Baszucki beneficially owns 17,200,000 shares of Common Stock individually. This total includes all shares of common stock acquired in private placements through September 30, 2023, open market acquisitions and dispositions of shares of common stock through September 30, 2023, and excludes warrants for the purchase of 1,000,000 shares of common stock. Mr. Baszucki beneficially owns 20.11% of the Common Stock outstanding, based on total shares of Common Stock outstanding as of May 15, 2024 of 85,512,166 shares of Common Stock, as confirmed by the Issuer. (b) As of October 16, 2023, Mr. Baszucki had sole voting power and sole dispositive power with respect to 17,200,000 common stock shares, excluding an additional 1,000,000 shares of Common Stock assuming exercise of all warrants to purchase common stock (which have been excluded from the Reporting Person’s total voting power). - 3 - (c) Within the 60 days prior to the filing of this Schedule 13D, Mr. Baszucki acquired /disposed of the following securities of the Issuer: On August 25, 2023, Mr. Baszucki purchased 10,000 shares of common stock at a purchase price of $0.6799 per shares through open market purchases. On September 7, 2023, Mr. Baszucki purchased 20,000 shares of common stock at a purchase price of $0.6299 per share through open market purchases. September 15, 2023, Mr. Baszucki purchased 245,545 shares of common stock at a purchase price of $0.5675 per share through open market purchases. On September 29, 2023, Mr. Baszucki purchased 14,000,000 shares of common stock at $0.25 per share pursuant to Issuer’s Registered Offering on Form S-1 declared effective September 26, 2023 (Registration No. 333-274350). September 25, 2023, Mr. Baszucki sold 96,517 shares of common stock at a sales price of $0.4538 per share through open market sales. September 26, 2023, Mr. Baszucki sold 200,000 shares of common stock at

Contracts, Arrangements, Understandings

Item 6. Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer Except as described herein, the Reporting Person nor any other person referred to in Item 2 herein, has any contract, arrangements understandings or relationship (legal or otherwise) with any person with respect to any securities of the Issuer, including but not limited to the transfer or voting of any of the securities, finder’s fees, joint ventures, loan or option arrangements, puts or calls, guarantees of profits, division of profits or losses, or the giving or withholding of proxies.

Material to Be Filed as Exhibits

Item 7. Material to Be Filed as Exhibits None. - 4 - SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Date: June 3, 2024 By: /s/ Todd Baszucki Name: Todd Baszucki - 5 -

View Full Filing

View this SC 13D/A filing on SEC EDGAR